Fmr Llc

13F Holdings History for Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.40 per share
Latest Disclosed Ownership: 10.2M shares
Security Ownership: 3.8%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL)

2025-05-12 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.2M shares of Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL). This represents 3.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	3.8%		$13.8M	10.2M			$1.36	13G/A	3/31/2025	12 May 2025 10:24:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$16.2M	7.11M	-3,056,763	-30.1%	$2.28	Q2 2025
3/31/2025	0%	0%	$15.8M	10.2M	-5,469,922		$1.55	Q1 2025
12/31/2024	0%	0%	$36.7M	15.6M	-2,141,603	-12%	$2.35	Q4 2024
9/30/2024	0%	+0%	$64.5M	17.8M	+5,478,706	+44.6%	$3.63	Q3 2024
6/30/2024	0%	+0%	$42.8M	12.3M	+3,278,777	+36.4%	$3.48	Q2 2024
3/31/2024	0%	+0%	$57.5M	9.02M	+9,014,165	+405131%	$6.38	Q1 2024
12/31/2023	0%		$14.3K	2.23K			$6.44	Q4 2023
9/30/2023	0%		$5.18K	2.23K	+1,092	+96.4%	$2.33	Q3 2023
6/30/2023	0%		$2.7K	1.13K			$2.38	Q2 2023
3/31/2023	0%		$2.09K	1.13K			$1.84	Q1 2023
12/31/2022	0%	0%	$2.15K	1.13K	-380,185	-99.7%	$1.90	Q4 2022
9/30/2022	0%		$816K	381K	+1,133	+0.3%	$2.14	Q3 2022
6/30/2022	0%	0%	$1.08M	380K	-1,262,100	-76.9%	$2.83	Q2 2022
3/31/2022	0%		$6.85M	1.64M			$4.17	Q1 2022
12/31/2021	0%	+0%	$8.52M	1.64M	+140,297	+9.34%	$5.19	Q4 2021
9/30/2021	0%	0%	$9.84M	1.5M	-568,500	-27.5%	$6.55	Q3 2021
6/30/2021	0%		$13.7M	2.07M			$6.64	Q2 2021
3/31/2021	0%	+0%	$11.9M	2.07M	+1,957,721	+1736%	$5.73	Q1 2021
12/31/2020	0%	+0%	$1.01M	113K	+58,773	+109%	$8.94	Q4 2020
9/30/2020	0%	0%	$628K	54K	-34,014	-38.6%	$11.63	Q3 2020
6/30/2020	0%	0%	$1.41M	88K	-124,100	-58.5%	$16.03	Q2 2020
3/31/2020	0%		$1.27M	212K			$5.99	Q1 2020
12/31/2019	0%	0%	$2.8M	212K	-99,040	-31.8%	$13.20	Q4 2019
9/30/2019	0%	0%	$3.86M	311K	-62,652	-16.8%	$12.42	Q3 2019
6/30/2019	0%	+0%	$6.02M	374K	+373,800	NEW	$16.10	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.